|
Volumn 134, Issue 5, 2008, Pages
|
Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41
a
INTERCELL AG
(Austria)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
HEPATITIS C VACCINE;
HLA A2 ANTIGEN;
IC 41;
INTERFERON;
PEPTIDE VACCINE;
POLYARGININE;
RIBAVIRIN;
VIRUS RNA;
ABDOMINAL PAIN;
ADULT;
ARTHRALGIA;
ARTICLE;
CD8+ T LYMPHOCYTE;
CELL PROLIFERATION;
CHOLELITHIASIS;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTITIS;
DIARRHEA;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
DRUG TOLERABILITY;
ENZYME LINKED IMMUNOSPOT ASSAY;
ERYTHEMA;
FATIGUE;
FEMALE;
FEVER;
FLU LIKE SYNDROME;
FLUORESCENCE ACTIVATED CELL SORTING;
HEADACHE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INFLUENZA;
INJECTION SITE EDEMA;
INJECTION SITE ERYTHEMA;
INJECTION SITE INDURATION;
INJECTION SITE PAIN;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTICENTER STUDY;
NAUSEA;
NIGHT SWEAT;
NONHUMAN;
PATHOGENESIS;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
RHINOPHARYNGITIS;
RIGOR;
SINUSITIS;
TOOTH PAIN;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
VACCINATION;
|
EID: 42949111104
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/j.gastro.2008.02.058 Document Type: Article |
Times cited : (137)
|
References (35)
|